Home/Filings/4/0001041602-05-000030

4//SEC Filing

SUNESIS PHARMACEUTICALS INC 4

Accession 0001041602-05-000030

$VIRXCIK 0001061027operating

View on SEC.gov Company Profile

Filed

Oct 3, 8:00 PM ET

Accepted

Oct 4, 7:14 PM ET

Size

36.5 KB

Accession

0001041602-05-000030

Insider Transaction Report

Form 4

Period: 2005-09-30

SUNESIS PHARMACEUTICALS INCSNSS

MAYFIELD IX MANAGEMENT LLC

Other

Transactions

Conversion
Common Stock
2005-09-30+61,405→ 61,405 total(indirect: by MF AIII)
Conversion
Series A Preferred Stock
2005-09-30−2,945,000→ 0 total
Exercise: $0.00→ Common Stock (535,455 underlying)
Purchase
Common Stock
2005-09-30$7.00/sh+3,500$24,500→ 64,905 total(indirect: by MF AIII)
Purchase
Common Stock
2005-09-30$7.00/sh+66,500$465,500→ 1,233,195 total
Conversion
Series A Preferred Stock
2005-09-30−155,000→ 0 total(indirect: by MF AIII)
Exercise: $0.00→ Common Stock (28,182 underlying)
Conversion
Common Stock
2005-09-30+1,166,695→ 1,166,695 total
Conversion
Series C Preferred Stock
2005-09-30−31,250→ 0 total(indirect: by MF AIII)
Exercise: $0.00→ Common Stock (16,466 underlying)
Conversion
Series C Preferred Stock
2005-09-30−593,750→ 0 total
Exercise: $0.00→ Common Stock (312,855 underlying)
Conversion
Series B Preferred Stock
2005-09-30−57,693→ 0 total(indirect: by MF AIII)
Exercise: $0.00→ Common Stock (16,757 underlying)
Conversion
Series B Preferred Stock
2005-09-30−1,096,153→ 0 total
Exercise: $0.00→ Common Stock (318,385 underlying)

MAYFIELD IX

10% Owner

Transactions

Purchase
Common Stock
2005-09-30$7.00/sh+66,500$465,500→ 1,233,195 total
Purchase
Common Stock
2005-09-30$7.00/sh+3,500$24,500→ 64,905 total(indirect: by MF AIII)
Conversion
Series B Preferred Stock
2005-09-30−1,096,153→ 0 total
Exercise: $0.00→ Common Stock (318,385 underlying)
Conversion
Series A Preferred Stock
2005-09-30−155,000→ 0 total(indirect: by MF AIII)
Exercise: $0.00→ Common Stock (28,182 underlying)
Conversion
Series C Preferred Stock
2005-09-30−31,250→ 0 total(indirect: by MF AIII)
Exercise: $0.00→ Common Stock (16,466 underlying)
Conversion
Common Stock
2005-09-30+1,166,695→ 1,166,695 total
Conversion
Series B Preferred Stock
2005-09-30−57,693→ 0 total(indirect: by MF AIII)
Exercise: $0.00→ Common Stock (16,757 underlying)
Conversion
Series A Preferred Stock
2005-09-30−2,945,000→ 0 total
Exercise: $0.00→ Common Stock (535,455 underlying)
Conversion
Common Stock
2005-09-30+61,405→ 61,405 total(indirect: by MF AIII)
Conversion
Series C Preferred Stock
2005-09-30−593,750→ 0 total
Exercise: $0.00→ Common Stock (312,855 underlying)

MAYFIELD ASSOCIATES FUND III L P

Other

Transactions

Conversion
Series B Preferred Stock
2005-09-30−57,693→ 0 total(indirect: by MF AIII)
Exercise: $0.00→ Common Stock (16,757 underlying)
Conversion
Common Stock
2005-09-30+61,405→ 61,405 total(indirect: by MF AIII)
Conversion
Series C Preferred Stock
2005-09-30−31,250→ 0 total(indirect: by MF AIII)
Exercise: $0.00→ Common Stock (16,466 underlying)
Purchase
Common Stock
2005-09-30$7.00/sh+66,500$465,500→ 1,233,195 total
Conversion
Series B Preferred Stock
2005-09-30−1,096,153→ 0 total
Exercise: $0.00→ Common Stock (318,385 underlying)
Conversion
Series C Preferred Stock
2005-09-30−593,750→ 0 total
Exercise: $0.00→ Common Stock (312,855 underlying)
Conversion
Series A Preferred Stock
2005-09-30−155,000→ 0 total(indirect: by MF AIII)
Exercise: $0.00→ Common Stock (28,182 underlying)
Conversion
Common Stock
2005-09-30+1,166,695→ 1,166,695 total
Conversion
Series A Preferred Stock
2005-09-30−2,945,000→ 0 total
Exercise: $0.00→ Common Stock (535,455 underlying)
Purchase
Common Stock
2005-09-30$7.00/sh+3,500$24,500→ 64,905 total(indirect: by MF AIII)

MAYFIELD VIII MANAGEMENT LLC

Other

Transactions

Purchase
Common Stock
2005-09-30$7.00/sh+3,500$24,500→ 64,905 total(indirect: by MF AIII)
Conversion
Series B Preferred Stock
2005-09-30−1,096,153→ 0 total
Exercise: $0.00→ Common Stock (318,385 underlying)
Conversion
Series C Preferred Stock
2005-09-30−593,750→ 0 total
Exercise: $0.00→ Common Stock (312,855 underlying)
Conversion
Series C Preferred Stock
2005-09-30−31,250→ 0 total(indirect: by MF AIII)
Exercise: $0.00→ Common Stock (16,466 underlying)
Conversion
Common Stock
2005-09-30+1,166,695→ 1,166,695 total
Conversion
Series A Preferred Stock
2005-09-30−155,000→ 0 total(indirect: by MF AIII)
Exercise: $0.00→ Common Stock (28,182 underlying)
Conversion
Common Stock
2005-09-30+61,405→ 61,405 total(indirect: by MF AIII)
Purchase
Common Stock
2005-09-30$7.00/sh+66,500$465,500→ 1,233,195 total
Conversion
Series A Preferred Stock
2005-09-30−2,945,000→ 0 total
Exercise: $0.00→ Common Stock (535,455 underlying)
Conversion
Series B Preferred Stock
2005-09-30−57,693→ 0 total(indirect: by MF AIII)
Exercise: $0.00→ Common Stock (16,757 underlying)

FONG KEVIN A

Other

Transactions

Purchase
Common Stock
2005-09-30$7.00/sh+3,500$24,500→ 64,905 total(indirect: by MF AIII)
Conversion
Series A Preferred Stock
2005-09-30−2,945,000→ 0 total
Exercise: $0.00→ Common Stock (535,455 underlying)
Conversion
Common Stock
2005-09-30+1,166,695→ 1,166,695 total
Conversion
Series B Preferred Stock
2005-09-30−1,096,153→ 0 total
Exercise: $0.00→ Common Stock (318,385 underlying)
Conversion
Series B Preferred Stock
2005-09-30−57,693→ 0 total(indirect: by MF AIII)
Exercise: $0.00→ Common Stock (16,757 underlying)
Purchase
Common Stock
2005-09-30$7.00/sh+66,500$465,500→ 1,233,195 total
Conversion
Series C Preferred Stock
2005-09-30−593,750→ 0 total
Exercise: $0.00→ Common Stock (312,855 underlying)
Conversion
Common Stock
2005-09-30+61,405→ 61,405 total(indirect: by MF AIII)
Conversion
Series C Preferred Stock
2005-09-30−31,250→ 0 total(indirect: by MF AIII)
Exercise: $0.00→ Common Stock (16,466 underlying)
Conversion
Series A Preferred Stock
2005-09-30−155,000→ 0 total(indirect: by MF AIII)
Exercise: $0.00→ Common Stock (28,182 underlying)

UNGER WILLIAM D

Other

Transactions

Conversion
Common Stock
2005-09-30+1,166,695→ 1,166,695 total
Purchase
Common Stock
2005-09-30$7.00/sh+3,500$24,500→ 64,905 total(indirect: by MF AIII)
Purchase
Common Stock
2005-09-30$7.00/sh+66,500$465,500→ 1,233,195 total
Conversion
Series B Preferred Stock
2005-09-30−57,693→ 0 total(indirect: by MF AIII)
Exercise: $0.00→ Common Stock (16,757 underlying)
Conversion
Series B Preferred Stock
2005-09-30−1,096,153→ 0 total
Exercise: $0.00→ Common Stock (318,385 underlying)
Conversion
Series C Preferred Stock
2005-09-30−31,250→ 0 total(indirect: by MF AIII)
Exercise: $0.00→ Common Stock (16,466 underlying)
Conversion
Series C Preferred Stock
2005-09-30−593,750→ 0 total
Exercise: $0.00→ Common Stock (312,855 underlying)
Conversion
Common Stock
2005-09-30+61,405→ 61,405 total(indirect: by MF AIII)
Conversion
Series A Preferred Stock
2005-09-30−2,945,000→ 0 total
Exercise: $0.00→ Common Stock (535,455 underlying)
Conversion
Series A Preferred Stock
2005-09-30−155,000→ 0 total(indirect: by MF AIII)
Exercise: $0.00→ Common Stock (28,182 underlying)

MYERS FRANK G JR

Other

Transactions

Conversion
Series A Preferred Stock
2005-09-30−2,945,000→ 0 total
Exercise: $0.00→ Common Stock (535,455 underlying)
Conversion
Series C Preferred Stock
2005-09-30−31,250→ 0 total(indirect: by MF AIII)
Exercise: $0.00→ Common Stock (16,466 underlying)
Conversion
Series A Preferred Stock
2005-09-30−155,000→ 0 total(indirect: by MF AIII)
Exercise: $0.00→ Common Stock (28,182 underlying)
Conversion
Common Stock
2005-09-30+1,166,695→ 1,166,695 total
Purchase
Common Stock
2005-09-30$7.00/sh+3,500$24,500→ 64,905 total(indirect: by MF AIII)
Purchase
Common Stock
2005-09-30$7.00/sh+66,500$465,500→ 1,233,195 total
Conversion
Series B Preferred Stock
2005-09-30−57,693→ 0 total(indirect: by MF AIII)
Exercise: $0.00→ Common Stock (16,757 underlying)
Conversion
Series B Preferred Stock
2005-09-30−1,096,153→ 0 total
Exercise: $0.00→ Common Stock (318,385 underlying)
Conversion
Common Stock
2005-09-30+61,405→ 61,405 total(indirect: by MF AIII)
Conversion
Series C Preferred Stock
2005-09-30−593,750→ 0 total
Exercise: $0.00→ Common Stock (312,855 underlying)

HEIDRICH A GRANT III

Other

Transactions

Conversion
Common Stock
2005-09-30+1,166,695→ 1,166,695 total
Conversion
Common Stock
2005-09-30+61,405→ 61,405 total(indirect: by MF AIII)
Purchase
Common Stock
2005-09-30$7.00/sh+3,500$24,500→ 64,905 total(indirect: by MF AIII)
Conversion
Series A Preferred Stock
2005-09-30−2,945,000→ 0 total
Exercise: $0.00→ Common Stock (535,455 underlying)
Purchase
Common Stock
2005-09-30$7.00/sh+66,500$465,500→ 1,233,195 total
Conversion
Series C Preferred Stock
2005-09-30−593,750→ 0 total
Exercise: $0.00→ Common Stock (312,855 underlying)
Conversion
Series C Preferred Stock
2005-09-30−31,250→ 0 total(indirect: by MF AIII)
Exercise: $0.00→ Common Stock (16,466 underlying)
Conversion
Series B Preferred Stock
2005-09-30−1,096,153→ 0 total
Exercise: $0.00→ Common Stock (318,385 underlying)
Conversion
Series A Preferred Stock
2005-09-30−155,000→ 0 total(indirect: by MF AIII)
Exercise: $0.00→ Common Stock (28,182 underlying)
Conversion
Series B Preferred Stock
2005-09-30−57,693→ 0 total(indirect: by MF AIII)
Exercise: $0.00→ Common Stock (16,757 underlying)

AUKEN WENDELL G VAN III

Other

Transactions

Conversion
Series B Preferred Stock
2005-09-30−1,096,153→ 0 total
Exercise: $0.00→ Common Stock (318,385 underlying)
Purchase
Common Stock
2005-09-30$7.00/sh+66,500$465,500→ 1,233,195 total
Conversion
Common Stock
2005-09-30+1,166,695→ 1,166,695 total
Conversion
Common Stock
2005-09-30+61,405→ 61,405 total(indirect: by MF AIII)
Conversion
Series B Preferred Stock
2005-09-30−57,693→ 0 total(indirect: by MF AIII)
Exercise: $0.00→ Common Stock (16,757 underlying)
Conversion
Series C Preferred Stock
2005-09-30−593,750→ 0 total
Exercise: $0.00→ Common Stock (312,855 underlying)
Conversion
Series A Preferred Stock
2005-09-30−155,000→ 0 total(indirect: by MF AIII)
Exercise: $0.00→ Common Stock (28,182 underlying)
Conversion
Series A Preferred Stock
2005-09-30−2,945,000→ 0 total
Exercise: $0.00→ Common Stock (535,455 underlying)
Purchase
Common Stock
2005-09-30$7.00/sh+3,500$24,500→ 64,905 total(indirect: by MF AIII)
Conversion
Series C Preferred Stock
2005-09-30−31,250→ 0 total(indirect: by MF AIII)
Exercise: $0.00→ Common Stock (16,466 underlying)

DALAL YOGEN K

Other

Transactions

Purchase
Common Stock
2005-09-30$7.00/sh+3,500$24,500→ 64,905 total(indirect: by MF AIII)
Conversion
Series A Preferred Stock
2005-09-30−2,945,000→ 0 total
Exercise: $0.00→ Common Stock (535,455 underlying)
Conversion
Series B Preferred Stock
2005-09-30−1,096,153→ 0 total
Exercise: $0.00→ Common Stock (318,385 underlying)
Conversion
Series C Preferred Stock
2005-09-30−31,250→ 0 total(indirect: by MF AIII)
Exercise: $0.00→ Common Stock (16,466 underlying)
Conversion
Common Stock
2005-09-30+61,405→ 61,405 total(indirect: by MF AIII)
Conversion
Series C Preferred Stock
2005-09-30−593,750→ 0 total
Exercise: $0.00→ Common Stock (312,855 underlying)
Conversion
Common Stock
2005-09-30+1,166,695→ 1,166,695 total
Conversion
Series B Preferred Stock
2005-09-30−57,693→ 0 total(indirect: by MF AIII)
Exercise: $0.00→ Common Stock (16,757 underlying)
Purchase
Common Stock
2005-09-30$7.00/sh+66,500$465,500→ 1,233,195 total
Conversion
Series A Preferred Stock
2005-09-30−155,000→ 0 total(indirect: by MF AIII)
Exercise: $0.00→ Common Stock (28,182 underlying)

Footnotes (3)

[F1]The individual Reporting Persons are Managing Directors of Mayfield IX Management, LLC, the sole General Partner of Mayfield IX (MF IX), and they are also Managing Directors of Mayfield VIII Management, LLC, the sole General Partner of Mayfield Associates Fund III (MF AIII). The individual Reporting Persons may be deemed to have shared voting and dispositive power over the shares which are or may be deemed to be beneficially owned by MF IX and MF AIII, but disclaim such beneficial ownership, except to the extent of their pecuniary interest therein.
[F2]The filing of this statement shall not be deemed an admission that, for the purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the Reporting Persons are the beneficial owners of all such equity securities covered by this statement. Each of the Reporting Persons included in this filing hereby designates Mayfield IX as its designated filer of Forms 3, 4 and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder.
[F3]Upon closing of the initial public offering, all Preferred Stock held by MF IX converts to a cumulative total of 1,166,695 shares of Common Stock, and all Preferred Stock held by MF AIII converts to a cumulative total of 61,405 shares of Common Stock.

Documents

1 file

4
edgar.xmlPrimary
PRIMARY DOCUMENT

Issuer

SUNESIS PHARMACEUTICALS INC

CIK 0001061027

→

Entity typeoperating

IncorporatedDE

Related Parties

filerCIK 0001061027

Filing Metadata

Form type: 4
Filed: Oct 3, 8:00 PM ET
Accepted: Oct 4, 7:14 PM ET
Size: 36.5 KB

View on SEC.gov